[ABCL] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 23.89%
YoY- -349.93%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 9,954 9,179 6,599 10,056 12,192 21,545 101,383 -78.68%
PBT -42,747 -48,602 -39,276 -38,004 -48,148 -31,412 46,587 -
Tax -2,137 -1,452 -10,666 -7,476 -8,038 -1,519 19,963 -
NP -40,610 -47,150 -28,610 -30,528 -40,110 -29,893 26,624 -
Tax Rate - - - - - - -42.85% -
Total Cost 50,564 56,329 35,209 40,584 52,302 51,438 74,759 -22.92%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -407.98 -513.67 -433.55 -303.58 -328.99 -138.75 26.26 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.14 -0.16 -0.10 -0.11 -0.14 -0.10 0.08 -
EPS Diluted -0.14 -0.16 -0.10 -0.11 -0.14 -0.10 0.08 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.